Reza Zadno Procept Bio Robotics Corp (PRCT) insider trading activity

Reza Zadno is President, CEO of PROCEPT BioRobotics Corp. Currently has a direct ownership of 205,605 shares of PRCT, which is worth approximately $19.2 Million. The most recent transaction as insider was on Nov 20, 2024, when has been sold 26,420 shares (Common Stock) at a price of $92.94 per share, resulting in proceeds of $2,455,474. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 206K

20.45% 3M change

2.31% 12M change

Total Value Held $19.2 Million

Reza Zadno Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 20 2024	SELL Open market or private sale	$2,455,474 $92.94 p/Share	26,420 Reduced 11.39%	205,605 Common Stock
Nov 13 2024	SELL Open market or private sale	$2,489,556 $94.23 p/Share	26,420 Reduced 10.22%	232,025 Common Stock
Oct 30 2024	SELL Open market or private sale	$26,249,951 $91.0 p/Share	288,461 Reduced 52.74%	258,445 Common Stock
Oct 30 2024	BUY Exercise of conversion of derivative security	$1,260,574 $4.37 p/Share	288,461 Added 34.53%	546,906 Common Stock
Jul 31 2024	BUY Exercise of conversion of derivative security	$102,625 $4.37 p/Share	23,484 Added 8.33%	258,445 Common Stock
Mar 18 2024	SELL Open market or private sale	$263,242 $48.83 p/Share	5,391 Reduced 2.19%	241,319 Common Stock
Mar 06 2024	SELL Open market or private sale	$428,383 $46.67 p/Share	9,179 Reduced 3.59%	246,710 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	54,933 Added 17.67%	255,889 Common Stock
Oct 18 2023	BUY Exercise of conversion of derivative security	$22,496 $4.37 p/Share	5,148 Added 2.5%	200,956 Common Stock
Apr 28 2023	BUY Exercise of conversion of derivative security	$87,378 $4.37 p/Share	19,995 Added 9.27%	195,808 Common Stock
Apr 04 2023	BUY Exercise of conversion of derivative security	$87,496 $4.37 p/Share	20,022 Added 10.22%	175,813 Common Stock
Mar 16 2023	SELL Open market or private sale	$169,866 $31.84 p/Share	5,335 Reduced 3.31%	155,791 Common Stock
Feb 16 2023	BUY Grant, award, or other acquisition	-	65,789 Added 28.99%	161,126 Common Stock
Mar 31 2022	BUY Grant, award, or other acquisition	$1,154,987 $29.38 p/Share	39,312 Added 29.2%	95,337 Common Stock
Sep 17 2021	BUY Conversion of derivative security	-	3,394 Added 5.71%	56,025 Common Stock

Reza Zadno

President, CEO

Redwood City, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRCT shares.

Notify only if

Value

Insider Trading

Get notified when an Procept Bio Robotics Corp insider buys or sells PRCT shares.

Notify only if

Operation

Value

Type

News

Receive news related to PROCEPT BioRobotics Corp

Track Activities on PRCT

Account